Evidence map›Paper›PMID 30827895›Full record

ArticleDevelopmental cell2019

Rate of Progression through a Continuum of Transit-Amplifying Progenitor Cell States Regulates Blood Cell Production.

Hojun Li, Anirudh Natarajan, Jideofor Ezike, M Inmaculada Barrasa, Yenthanh Le, Zoë A Feder, Huan Yang, Clement Ma, Styliani Markoulaki, Harvey F Lodish

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Therapeutic efficacy ofJournal of traditional and complementary medicine · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Hojun LiWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Dana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02115, USA.
Anirudh NatarajanWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Jideofor EzikeComputational and Systems Biology Program, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
M Inmaculada BarrasaWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Yenthanh LeWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Zoë A FederWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Huan YangWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Clement MaDana-Farber/Boston Children's Hospital Cancer and Blood Disorders Center, Boston, MA 02215, USA.
Styliani MarkoulakiWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
Harvey F LodishWhitehead Institute for Biomedical Research, Cambridge, MA 02142, USA; Departments of Biology and Bioengineering, Massachusetts Institute of Technology, Cambridge, MA 02142, USA. Electronic address: lodish@wi.mit.edu.
Whitehead Institute for Biomedical Research · USMassachusetts Institute of Technology · USBoston Children's Hospital · USDana-Farber/Boston Children's Cancer and Blood Disorders Center · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
PATHOPHYSIOLOGY OF HUMAN BLOOD CELLST32HL007574 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI Daniel Evan Bauer · 1985 to 2026
$18.4M
MicroRNAs and hematopoietic differentiationR01DK068348 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LODISH, HARVEY F · 2004 to 2019
$8.3M
NHLBI NIH HHS P01 HL032262NHLBI NIH HHS T32 HL007574NIDDK NIH HHS R01 DK068348
6 · The paper itself

Abstract

The nature of cell-state transitions during the transit-amplifying phases of many developmental processes-hematopoiesis in particular-is unclear. Here, we use single-cell RNA sequencing to demonstrate a continuum of transcriptomic states in committed transit-amplifying erythropoietic progenitors, which correlates with a continuum of proliferative potentials in these cells. We show that glucocorticoids enhance erythrocyte production by slowing the rate of progression through this developmental continuum of transit-amplifying progenitors, permitting more cell divisions prior to terminal erythroid differentiation. Mechanistically, glucocorticoids prolong expression of genes that antagonize and slow induction of genes that drive terminal erythroid differentiation. Erythroid progenitor daughter cell pairs have similar transcriptomes with or without glucocorticoid stimulation, indicating largely symmetric cell division. Thus, the rate of progression along a developmental continuum dictates the absolute number of erythroid cells generated from each transit-amplifying progenitor, suggesting a paradigm for regulating the total output of differentiated cells in numerous other developmental processes.

Indexed as

AnimalsBlood CellsCell DifferentiationCell DivisionCell ProliferationCells, CulturedErythrocytesErythroid CellsErythroid Precursor CellsErythropoiesisGlucocorticoidsHematopoiesisHigh-Throughput Nucleotide SequencingMiceSingle-Cell AnalysisTranscriptomeGlucocorticoidserythropoiesishematopoiesisprogenitor cellself-renewalsingle-cell transcriptomicstransit-amplification

Identifiers

PMID30827895
PMCPMC6456386
OpenAlexW2919984261

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.